I

Incyte

Biopharmaceutical company pursuing drug discovery.

Senior Director, Executive Medical Director - Hematology Oncology Drug Development

Clinical Research OperationsUpdated on Nov 10
Full-timeWilmington, DE, USANo salary listedIn-person

About the Job

Requirements

  • An M.D. or D.O. degree is required.
  • A minimum of 3–5 years of experience in oncology drug development at a biotechnology or pharmaceutical company is required.
  • The candidate must be able to multitask and work in a dynamic environment.
  • Excellent written and verbal communication skills are required.

Responsibilities

  • Provide guidance for successful implementation and completion of investigator-initiated trials related to product development and a compound’s life-cycle management.
  • Implement the highest ethical and regulatory standards during investigation and development of anticancer agents.
  • Partner with medical affairs to support successful launches of future antineoplastic agents.
  • Detect and analyze emergent issues during clinical drug development and develop and implement mitigating strategies.
  • Represent the company at national and international medical and scientific meetings, including participating in advisory boards with key opinion leaders.
  • Liaise with discovery science to facilitate and advance investigational agents from preclinical stages to clinical development.
  • Serve as an oncology medical and scientific expert in defining design strategy and execution for anticancer drug development.
  • Collaborate with external vendors, including contract research organizations and external imaging and laboratory resources, as well as global pharmaceutical companies, to implement and conduct early-phase and global registration clinical studies.
  • Facilitate development of product-development documents, including clinical study protocols, informed consents, case report forms, clinical study reports, meeting abstracts, scientific journal publications, strategy documents, and project plans.
  • Interact with global regulatory bodies, including the FDA and EMA, and collaborate with internal regulatory experts; oversee clinical research plans and sections for Investigational New Drug applications and New Drug Applications.
  • Provide medical and scientific expertise to internal cross-functional team members working on specific antineoplastic agents, including discovery scientists, medical scientists, biostatisticians, pharmacokineticists, pharmacovigilance, and clinical operations.

Desired Qualifications

  • Board certification or eligibility in Oncology is preferred.

About the Company

Incyte

Biopharmaceutical company pursuing drug discovery.

Incyte develops and sells medicines by discovering and developing new drugs, focusing on diseases in inflammation, autoimmunity, and blood cancers. Its core product, Jakafi (ruxolitinib), is a JAK1/2 inhibitor approved to treat a rare blood cancer and works by blocking JAK enzymes to reduce abnormal blood cell growth. The company also expands its pipeline through research collaborations, partnerships, and acquisitions, such as the 2024 purchase of Escient Pharmaceuticals to strengthen its inflammation and autoimmune portfolio. Unlike some competitors that rely mainly on internal programs, Incyte combines in-house discovery with external collaborations and strategic deals to grow its drug candidates from early research to approved therapies. The goal is to deliver medicines that help patients with serious diseases by building a diverse, clinically validated portfolio of treatments through internal efforts and partnerships.

Company size
1,001-5,000
Company stage
IPO
Headquarters
Wilmington, DE
Founded
1991

Recently Posted Jobs

Explore more opportunities at Incyte

See more jobs